K Doležalova-Kormanova1,2, J N Buchwald3, D Skochova4, D Pichlerova5, T W McGlennon6, M Fried7,5. 1. First Faculty of Medicine, Charles University, Prague, Czech Republic. karinkorm@seznam.cz. 2. OB Klinika a.s, Pod Krejcarkem 975, 130 00, Prague 3, Czech Republic. karinkorm@seznam.cz. 3. Division of Scientific Research Writing, Medwrite Medical Communications, Maiden Rock, WI, USA. 4. General University Hospital, Prague, and Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic. 5. OB Klinika a.s, Pod Krejcarkem 975, 130 00, Prague 3, Czech Republic. 6. Statistical Analysis and Quality of Life Assessment, McGlennon MotiMetrics, Maiden Rock, WI, USA. 7. First Faculty of Medicine, Charles University, Prague, Czech Republic.
Abstract
BACKGROUND: Laparoscopic greater curvature plication (LGCP) is a newer metabolic/bariatric surgical procedure that requires no resection, bypass, or implantable device. We report outcomes in a cohort of LGCP patients at 5-year follow-up. METHODS: Body mass index (BMI, kg/m2) evolution, excess weight loss (%EWL), excess BMI loss (%EBMIL), and total weight loss (%TWL) were recorded. Repeated measures analysis of variance (ANOVA) was used to assess BMI change over 5 years. Two-step cluster analysis was used to profile LGCP patients according to significant characteristics relative to successful 5-year weight loss. RESULTS: Of patients entering the study between 2010 and 2011 with complete weight data through 5-year follow-up (86.9%, 212/244), mean age was 45.8 ± 10.9 years; mean baseline BMI, 41.4 ± 5.5 (81.6% women); 58 patients (27.4%) had type 2 diabetes. Mean operative time was 69.0 min; mean hospitalization, 38 h (24-72). ANOVA indicated a significant BMI reduction out to 2 years (p < 0.001), a plateau at 3 and 4 years, and a moderate but significant BMI increase at 5 years (p < 0.01). EBMIL at 1, 2, 3, 4, and 5 years was as follows: 50.7 ± 9.1%, 61.5 ± 8.1%, 60.2 ± 7.0%, 58.5 ± 7.0%, and 56.8 ± 6.3%. At 5 years, 79.2% (168/212) of patients were successful; 20.8% (44/212) experienced a suboptimal weight outcome; mean weight regain, 9.2%. Cluster analysis identified four distinct LGCP patient profiles. Diabetes improvement rate was 65.5%. There were 12 reoperations (4.9%): 4 emergency (1.6%) and 8 (3.3%) elective. There was no mortality. CONCLUSIONS: At 5-year follow-up, LGCP proved to be safe and effective, with 56.8% EBMIL and a low rate of complications.
BACKGROUND: Laparoscopic greater curvature plication (LGCP) is a newer metabolic/bariatric surgical procedure that requires no resection, bypass, or implantable device. We report outcomes in a cohort of LGCPpatients at 5-year follow-up. METHODS: Body mass index (BMI, kg/m2) evolution, excess weight loss (%EWL), excess BMI loss (%EBMIL), and total weight loss (%TWL) were recorded. Repeated measures analysis of variance (ANOVA) was used to assess BMI change over 5 years. Two-step cluster analysis was used to profile LGCPpatients according to significant characteristics relative to successful 5-year weight loss. RESULTS: Of patients entering the study between 2010 and 2011 with complete weight data through 5-year follow-up (86.9%, 212/244), mean age was 45.8 ± 10.9 years; mean baseline BMI, 41.4 ± 5.5 (81.6% women); 58 patients (27.4%) had type 2 diabetes. Mean operative time was 69.0 min; mean hospitalization, 38 h (24-72). ANOVA indicated a significant BMI reduction out to 2 years (p < 0.001), a plateau at 3 and 4 years, and a moderate but significant BMI increase at 5 years (p < 0.01). EBMIL at 1, 2, 3, 4, and 5 years was as follows: 50.7 ± 9.1%, 61.5 ± 8.1%, 60.2 ± 7.0%, 58.5 ± 7.0%, and 56.8 ± 6.3%. At 5 years, 79.2% (168/212) of patients were successful; 20.8% (44/212) experienced a suboptimal weight outcome; mean weight regain, 9.2%. Cluster analysis identified four distinct LGCPpatient profiles. Diabetes improvement rate was 65.5%. There were 12 reoperations (4.9%): 4 emergency (1.6%) and 8 (3.3%) elective. There was no mortality. CONCLUSIONS: At 5-year follow-up, LGCP proved to be safe and effective, with 56.8% EBMIL and a low rate of complications.
Authors: Jeffrey I Mechanick; Robert F Kushner; Harvey J Sugerman; J Michael Gonzalez-Campoy; Maria L Collazo-Clavell; Safak Guven; Adam F Spitz; Caroline M Apovian; Edward H Livingston; Robert Brolin; David B Sarwer; Wendy A Anderson; John Dixon Journal: Surg Obes Relat Dis Date: 2008-08-19 Impact factor: 4.734
Authors: Toni El Soueidy; Radwan Kassir; Mary Nakhoul; Axel Balian; Marco Nunziante; Maissa Safieddine; Gabriel Perlemuter; Panagiotis Lainas; Ibrahim Dagher Journal: Obes Surg Date: 2020-11-19 Impact factor: 4.129
Authors: Daniel Toman; Petr Vavra; Petr Jelinek; Petr Ostruszka; Peter Ihnat; Ales Foltys; Anton Pelikan; Jan Roman Journal: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Date: 2021-04-19 Impact factor: 1.245
Authors: Hauke Heinrich Georg Meyer; Romualdas Riauka; Zilvinas Dambrauskas; Antanas Mickevicius Journal: Wideochir Inne Tech Maloinwazyjne Date: 2020-07-21 Impact factor: 1.195